PDS Biotechnology shares are trading higher after the company announced 12-month survival data for PDS0101 in combination with KEYTRUDA.
Portfolio Pulse from Bill Haddad
PDS Biotechnology shares are trading higher following the announcement of positive 12-month survival data for PDS0101 in combination with KEYTRUDA.
May 26, 2023 | 3:37 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
PDS Biotechnology shares are trading higher after announcing positive 12-month survival data for PDS0101 in combination with KEYTRUDA.
The positive 12-month survival data for PDS0101 in combination with KEYTRUDA is a significant milestone for PDS Biotechnology. This news is likely to boost investor confidence in the company's product pipeline and drive the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100